Stockreport

Celcuity (CELC) Is Up 7.6% After FDA Accepts Gedatolisib Application for Expedited Review - What's Changed [Yahoo! Finance]

Celcuity Inc.  (CELC) 
Last celcuity inc. earnings: 3/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: celcuity.com/home/investors
PDF Food and Drug Administration for gedatolisib, targeting hormone receptor positive, HER2 negative advanced breast cancer, under the Real-Time Oncology Review program. T [Read more]